Downloads e Consultas - Períodos Fixos
No caso de registos com mais do que um ficheiro, o número total de downloads e consultas é dividido pelo número de ficheiros associados ao documento.
Número de downloads e consultas no período.
Número de downloads e consultas no período.
Documento
| Título | : | Psoralen analogues: synthesis, inhibitory activity of growth of human tumor cell lines and computational studies |
| Data entrada | : | 26-06-2006 |
Downloads e ConsultasExport
| Ano | Downloads | Consultas |
| 2006 | 33,0 | 45 |
| 2007 | 54,0 | 36 |
| 2008 | 94,0 | 42 |
| 2009 | 64,0 | 45 |
| 2010 | 99,0 | 34 |
| 2011 | 137,0 | 20 |
| 2012 | 106,0 | 7 |
| 2013 | 111,0 | 9 |
| 2014 | 56,0 | 4 |
| 2015 | 59,0 | 0 |
| 2016 | 63,0 | 2 |
| 2017 | 8,0 | 2 |
| 2018 | 7,0 | 2 |
| 2019 | 23,0 | 14 |
| 2020 | 19,0 | 4 |
| 2021 | 34,0 | 9 |
| 2022 | 13,0 | 8 |
| 2023 | 10,0 | 4 |
| 2024 | 14,0 | 2 |
| 1.004,0 | 289 |
Downloads e Consultas por ano
Downloads por país (top 10)
Consultas por país (top 10)
Downloads por paísExport
| Origem | Downloads | Perc.(%) |
 India |
190,0 | 19,25 |
 United States |
140,0 | 14,18 |
 China |
69,0 | 6,99 |
 Portugal |
61,0 | 6,18 |
 Germany |
31,0 | 3,14 |
 Iran, Islamic Republic of |
25,0 | 2,53 |
 Brazil |
25,0 | 2,53 |
 United Kingdom |
25,0 | 2,53 |
 Italy |
24,0 | 2,43 |
 Universidade do Minho |
22,0 | 2,23 |
 Indonesia |
22,0 | 2,23 |
 Japan |
21,0 | 2,13 |
 Egypt |
20,0 | 2,03 |
 France |
18,0 | 1,82 |
 Pakistan |
15,0 | 1,52 |
 Korea, Republic of |
14,0 | 1,42 |
 Poland |
14,0 | 1,42 |
 Mexico |
13,0 | 1,32 |
 Turkey |
10,0 | 1,01 |
 Serbia |
10,0 | 1,01 |
 Taiwan |
10,0 | 1,01 |
 Saudi Arabia |
9,0 | 0,91 |
 Singapore |
9,0 | 0,91 |
 Canada |
9,0 | 0,91 |
 Thailand |
8,0 | 0,81 |
 Netherlands |
8,0 | 0,81 |
 Switzerland |
8,0 | 0,81 |
 Russian Federation |
7,0 | 0,71 |
 Vietnam |
7,0 | 0,71 |
 Spain |
7,0 | 0,71 |
 Peru |
6,0 | 0,61 |
 N/A |
6,0 | 0,61 |
 Hong Kong |
5,0 | 0,51 |
 Greece |
5,0 | 0,51 |
 Australia |
5,0 | 0,51 |
 South Africa |
4,0 | 0,41 |
 Malaysia |
4,0 | 0,41 |
 Colombia |
4,0 | 0,41 |
 Chile |
4,0 | 0,41 |
 Ukraine |
4,0 | 0,41 |
 Tunisia |
4,0 | 0,41 |
 Croatia |
4,0 | 0,41 |
 Kazakstan |
4,0 | 0,41 |
 Albania |
4,0 | 0,41 |
 Cote D'Ivoire |
3,0 | 0,30 |
 Ireland |
3,0 | 0,30 |
 Iraq |
3,0 | 0,30 |
 Guadeloupe |
3,0 | 0,30 |
 Kenya |
3,0 | 0,30 |
 Qatar |
3,0 | 0,30 |
 Sri Lanka |
3,0 | 0,30 |
 Sweden |
3,0 | 0,30 |
 Cameroon |
3,0 | 0,30 |
 Israel |
2,0 | 0,20 |
 United Arab Emirates |
2,0 | 0,20 |
 Nigeria |
2,0 | 0,20 |
 Sudan |
2,0 | 0,20 |
 Philippines |
2,0 | 0,20 |
 Latvia |
2,0 | 0,20 |
 Slovenia |
2,0 | 0,20 |
 Lebanon |
2,0 | 0,20 |
 Guatemala |
2,0 | 0,20 |
 Belgium |
2,0 | 0,20 |
 Austria |
2,0 | 0,20 |
 Czech Republic |
2,0 | 0,20 |
 Romania |
2,0 | 0,20 |
 Bulgaria |
1,0 | 0,10 |
 Uzbekistan |
1,0 | 0,10 |
 Ecuador |
1,0 | 0,10 |
 Argentina |
1,0 | 0,10 |
 Jordan |
1,0 | 0,10 |
 Slovakia |
1,0 | 0,10 |
 Myanmar |
1,0 | 0,10 |
 Libyan Arab Jamahiriya |
1,0 | 0,10 |
 Ethiopia |
1,0 | 0,10 |
 Puerto Rico |
1,0 | 0,10 |
 Denmark |
1,0 | 0,10 |
 Madagascar |
1,0 | 0,10 |
 Angola |
1,0 | 0,10 |
 Panama |
1,0 | 0,10 |
 Algeria |
1,0 | 0,10 |
 Venezuela |
1,0 | 0,10 |
 Lithuania |
1,0 | 0,10 |
 Reunion |
1,0 | 0,10 |
 Uruguay |
1,0 | 0,10 |
 Bolivia |
1,0 | 0,10 |
| 987,0 | 100,00 |
Consultas por paísExport
| Origem | Consultas | Perc.(%) |
|
Portugal |
72 | 27,38 |
|
Universidade do Minho |
63 | 23,95 |
|
Brazil |
45 | 17,11 |
|
United States |
26 | 9,89 |
|
India |
10 | 3,80 |
|
China |
9 | 3,42 |
|
France |
6 | 2,28 |
|
Spain |
4 | 1,52 |
|
United Kingdom |
3 | 1,14 |
|
Netherlands |
3 | 1,14 |
|
Mexico |
3 | 1,14 |
|
Egypt |
2 | 0,76 |
|
Italy |
2 | 0,76 |
|
Germany |
2 | 0,76 |
|
Iran, Islamic Republic of |
2 | 0,76 |
|
N/A |
1 | 0,38 |
|
Colombia |
1 | 0,38 |
|
Saudi Arabia |
1 | 0,38 |
|
Japan |
1 | 0,38 |
|
Greece |
1 | 0,38 |
|
Ukraine |
1 | 0,38 |
|
Romania |
1 | 0,38 |
|
Tunisia |
1 | 0,38 |
|
Switzerland |
1 | 0,38 |
|
Denmark |
1 | 0,38 |
|
Slovakia |
1 | 0,38 |
| 263 | 100,00 |